2999-40-8Relevant articles and documents
COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPASE
-
Paragraph 0097; 00120, (2019/04/09)
Compounds of general formula IA, IB and IC outlined below, including pharmaceutically acceptable salts, solvates and hydrates thereof. Such compounds and pharmaceutical compositions comprising them may be used in medical conditions involving Ran GTPase.
Protection of COOH and OH groups in acid, base and salt free reactions
Zhu, Xiaotao,Qian, Bo,Wei, Rongbiao,Huang, Jian-Dong,Bao, Hongli
supporting information, p. 1444 - 1447 (2018/04/12)
We report an iron-catalyzed general functional group protection method with inexpensive reagents. This environmentally benign process does not use acids or bases, and does not produce waste products. Further purification beyond filtration and evaporation is, in most cases, unnecessary. Free COOH and OH groups can be protected in a one-pot reaction.
Synthesis and antibacterial activity of new symmetric polyoxygenated dibenzofurans
Oramas-Royo, Sandra,Pantoja, Kriss Dayana,Amesty, ángel,Romero, Carmen,Lorenzo-Castrillejo, Isabel,Machín, Félix,Estévez-Braun, Ana
, p. 178 - 187 (2017/10/16)
A series of symmetric polyoxygenated dibenzofurans with 2-methylbutyril moieties at C-4 and C-6 were obtained from commercial phloroglucinol through a sequence of reactions that include monoacylation, iodination, Suzuki-Miyaura coupling, oxidative dimeriz